C M Bidwell & Associates LTD Invitae Corp Transaction History

C M Bidwell & Associates LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.01 - $0.61 $8 - $499	-819 Reduced 87.97%	112 $0
Q4 2022 Feb 10, 2023	BUY	$1.71 - $3.61 $1,592 - $3,360	931 New	931 $1,000
Q2 2022 Aug 12, 2022	SELL	$2.13 - $9.01 $238 - $1,009	-112 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$6.28 - $15.59 $703 - $1,746	112 New	112 $1,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.